院長

陳家亮教授, 太平紳士

院長

卓敏內科及藥物治療系講座教授
腸道微生物群研究中心主任

院長

陳家亮教授, 太平紳士

內科及藥物治療學系

聯絡資料
電話 : -
電郵 : dean@med.cuhk.edu.hk


學院/ 學系 / 研究所 / 研究中心 / 單位
內科及藥物治療學系

專業範疇
消化性潰瘍、腸胃出血、幽門螺旋菌、治療性內鏡研究及大腸癌

學歷
1988 MBChB (Hons), CUHK
1998 MD, CUHK
2011 DSc, CUHK

專業資格
1995 香港內科醫學院院士(腸胃及肝臟科)
1995 香港醫學專科學院院士 (內科)
1999 愛爾蘭皇家內科醫學院榮授院士
2000 英國愛丁堡皇家內科醫學院榮授院士
2003 美國腸胃病學會榮授院士
2004 英國倫敦皇家內科醫學院榮授院士
2018 泰國皇家醫師學院榮譽院士

專注研究
消化性潰瘍、腸胃出血、幽門螺旋菌、治療性內鏡研究及大腸癌

更多資訊
榮譽及奬項 (國家級、國際級)
2005 David Y. Graham Lecturer (The American College of Gastroenterology)
2007 The State Scientific and Technological Progress Award (National Office for Science and Technology Awards, PRC)
2008 Andy Martynoga Memorial Lecturer
2007-08 Croucher Senior Medical Research Fellowship
2011 JGHF Marshall and Warren Lecturer
2016 19th Vikit Viranuvatti’s Lecturer
2018 2018 International Leadership Award (The American College of Gastroenterology)

法定機構服務
Board Member Hong Kong Hospital Authority
Member   Colorectal Cancer Screening Pilot Programme Task Force, Department of Health
Permanent Member Expert Panel of Central Research Working Group for Hospital Authority, Chinese Medicine Research,
Hong Kong Hospital Authority
Member Governing Board, Hong Kong Jockey Club Disaster Preparedness and Response Institute, Hong Kong Academy of Medicine
Convenor Endoscopy Task Force of Project Steering Committee on Standards for Ambulatory Facilities, Department of Health
Ex-officio Member Research Fellowship Assessment Panel, Food and Health Bureau

其他服務 (專業及社區)
Member, External Review Committee, Hong Kong Sanatorium & Hospital (Oct 2017 – Sep 2020)
Honorary Advisor, Hong Kong Association for Integration of Chinese-Western Medicine (Dec 2017 – present)
Advisor on Education, Peking Union Medical College (PUMC) (Sept 2012 – present)
評審專家,  衛生部科技教育, 中華人民共和國衛生部衛生行業科研專項項目評審專家 (Mar 2013 – Feb 2016)
Panelist, Global Panel of Clinicians and Clinical Researchers, Nature [to help Nature select a list of high-quality clinical journals for inclusion in the Nature Index] (Feb 2016 – present)
Nominator, 2016 Future Science Prize, Beijing, China
External Assessor in Gastroenterology, University of Malaya, Malaysia (Mar 2016 – present)
Leader, Task Force for Developing Clinical Practice Guidelines for Clinicians in Asia Pacific Countries, appointed by Asian Pacific Association of Gastroenterology and the Asian Pacific Society of Digestive Endoscopy (May 2016 – present)
Member, Open Fund Large Collaborative Grant Review Panel, National Medical Research Council, Ministry of Health, Singapore (Jul 2018 – Apr 2021)

簡歷(只提供英文版本)
部份論文

Professor Chan has published more than 500 full scientific articles in high impact factor international journals such as New England Journal of Medicine, Lancet and Gastroenterology with an H-index 94.
 
  1. Chan FK, et al. Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial. Lancet 2017;389:2375-82.
  2. Chan FK, et al. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): arandomised trial. Lancet 2010;376:173-9.
  3. Chan FK, et al. Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial. Lancet 2007;369:1621-6.
  4. Chan FK, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med 2005;352:238-44.
  5. Chan FK, et al. Eradication of Helicobacter pylori and the risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: A randomised trial. Lancet 2002;359:9-13.
  6. Chan FK, et al. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med 2002;347:2104-10.
  7. Chan FK, et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001;344:967-73.
  8. Chan FK, et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997;350:975-97.